RZLT Prakiraan wutah bathi kanggo taun ngarep rezolutebio.com
Rezolute, Inc. (RZLT) aims to secure a monopoly position in the treatment of rare endocrine pathologies through its drug RZ358. A shift in the consensus earnings per share forecast confirms these expectations, with the value 29.60 describing the current level. The company is implementing eco-friendly chemical disposal in its laboratories, and its market capitalization depends on clinical trial outcomes, rendering the asset decoupled from macroeconomic trends.
RZLT (rezolutebio.com): rincian analitis lan laporan miturut indikator
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Rezolute, Inc.|RZLT - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Rezolute|RZLT - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Rezolute|RZLT - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Rezolute|Rasio cepet rezolutebio.com
- data bathi resik lan rasio valuasi:
RZLT - Penghasilan resik perusahaan|Bathi mangsa ngarep Rezolute, Inc.|RZLT - Kapitalisasi marang bathi resik|Rega marang bathi mangsa ngarep Rezolute, Inc.|RZLT - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rezolute|RZLT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Rezolute|RZLT - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan rezolutebio.com|RZLT - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Rezolute, Inc.
- data total pendapatan lan volume dodolan:
Analisis wiwitan perusahaan:RZLT, Rezolute Corp
This indicator measures the expected earnings per share (EPS) dynamics, allowing investors to assess the market consensus regarding future business performance and adjust the asset's risk profile in a timely manner. When analyzing the projected net income per share growth for year n+1, it should be noted that for Rezolute, Inc. (RZLT), the potential for monetizing endocrinology patents depends directly on FDA approval, making current forecasts an indicator of market confidence in the success of clinical trials.
Analisis perusahaan pesaing
ASND (Ascendis Pharma Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Corp|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (rhythmtx.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Akero AKRO|Metsera, Inc. (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Therapeutics, Inc.|89bio Inc (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agios Pharmaceuticals Inc (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep Structure Corp GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group, Inc. MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep LXRX|MBX Biosciences - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Altimmune Inc|AARD (Aardvark Therapeutics Corp) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep SGMT (Sagimet Biosciences Inc)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioAge Labs, Inc.|Prakiraan wutah bathi resik saben saham ing taun ngarep biomeafusion.com BMEA|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Quince Therapeutics (QNCX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep GUTS (Fractyl Health Inc.)|vTv Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Agape ATP Corp ATPC|PLUR: Prakiraan wutah bathi saben saham kanggo taun ngarep|Synlogic, Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Matinas BioPharma Holdings (MTNB)|Prakiraan wutah bathi saben saham kanggo taun ngarep SPRB|GLTO: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTCX|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep lumos-pharma.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Organovo ONVO|RDUS: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep
